Target intelligence / Profile preview

Centromere protein A (CENP-A)

Target
CENP-A
Molecular classification
Histone variant, Chromatin-associated protein, Epigenetic marker, Other
01

Overview

Centromere protein A (CENP-A) is a histone H3 variant that serves as the principal epigenetic marker defining the position of the centromere on chromosomes in almost all eukaryotes, including humans[3][5]. By replacing canonical histone H3 in a subset of centromeric nucleosomes, CENP-A ensures correct kinetochore assembly and thus accurate chromosome segregation during mitosis[1][3][5]. CENP-A–containing nucleosomes are critical for heritable propagation of centromere identity and function independently of underlying DNA sequence, relying instead on a self-sustaining, epigenetic mechanism[3][5]. It directly interacts with proteins such as CENP-C and CENP-N to anchor kinetochore components[3][5]. Proper localization and function of CENP-A are essential; its misregulation is linked to chromosomal instability, a hallmark of many cancers[5][3]. Additionally, CENP-A is a known autoantigen in some autoimmune diseases[3]. No drugs currently target CENP-A directly, but it is under investigation as a cancer biomarker, and experimental efforts are ongoing to modulate its levels for research or therapeutic purposes[5][3].

Other names
Histone H3-like centromeric protein ACENPACentromere autoantigen ACenH3centromere-specific histone17kDa centromere protein
02

Biological functions

Centromere identity specificationEpigenetic maintenance of centromere positionKinetochore assemblyChromosome segregation during mitosisRegulation of sister chromatid cohesion
03

Disease associations

Cancer (especially chromosomal instability in various tumors)Other (autoimmune response, e.g., detected as autoantigen in CREST syndrome)
04

Safety considerations

Potential risks with inhibition or targeted depletion may include defective chromosome segregation and aneuploidyEssential for cell viability; loss-of-function leads to cell death or severe chromosomal instability
05

Biomarkers

CENP-A overexpression or mislocalization as a biomarker of cancer progression and prognosisCENP-A autoantibodies as diagnostic marker in autoimmune centromere syndromes (e.g., CREST)

Beyond the preview

Go deeper on Centromere protein A (CENP-A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Centromere protein A (CENP-A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call